{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Breast Cancer", "Carcinogenicity", "Hormone Receptors", "Hormonotherapy", "Natural Products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35057779", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "08"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "20"}], "Language": ["eng"], "ELocationID": ["18", "10.1186/s12906-022-03506-3"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "20"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells.", "Pagination": {"StartPage": "18", "MedlinePgn": "18"}, "Abstract": {"AbstractText": ["Breast Cancer (BC) is the most common cancer in women worldwide and, although 70% of patients are responsive to selective Estrogen Receptor (ER) modulators such as Tamoxifen (Tam), patients' survival is comprised by resistance to endocrine therapy. Brazilian flora, especially the Amazon biome, is one of the richest global sources of native species with potentially bioactive compounds. Arrabidaea chica is a plant native to the Amazon that has been used in the treatment of different diseases. However, its action on BC remains unclear.", "Herein the biological effects of the chloroform extract of A. chica (CEAC) were evaluated on BC cells and in in vivo model. After confirmation of CEAC antioxidant capacity, cells were treated with CEAC and Tam, alone and with CEAC+Tam. The cell viability was evaluated by MTT and hormone receptor transcripts levels were assessed (ESR1, ESR2 and AR). Finally, anticarcinogenicity of CEAC was recorded in Drosophila melanogaster through Epithelial Tumor Test (ETT).", "The study confirmed the antioxidant activity of CEAC. CEAC was selective for MCF-7, downregulating ESR2 and AR transcripts and upregulating ESR2 expression. The modulatory effects of CEAC on ERs did not differ between cells treated with Tam and with CEAC+Tam. Interestingly, previous treatment with CEAC, followed by treatment with Tam promoted a significant decrease in cell viability. The extract also presented anticarcinogenic effect in in vivo assay.", "The bioassays on breast tumor cells demonstrated the antiproliferative activity of the extract, which modulated the expression of\u00a0hormone receptors and sensitized luminal tumor cells to Tam. These results suggest that CEAC could be a complementary treatment for BC."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil."}], "LastName": "Brand\u00e3o", "ForeName": "Douglas C", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Cytogenetic and Mutagenesis, University Center of Patos de Minas, Patos de Minas, MG, Brazil."}], "LastName": "Lima", "ForeName": "Paula M A P", "Initials": "PMAP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil."}], "LastName": "Martins", "ForeName": "Isabella C", "Initials": "IC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil."}], "LastName": "Cordeiro", "ForeName": "Carina S", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil."}], "LastName": "Cordeiro", "ForeName": "Antonielle O", "Initials": "AO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil."}], "LastName": "Vecchi", "ForeName": "Lara", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, Brazil."}], "LastName": "Guerra", "ForeName": "Joyce F C", "Initials": "JFC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cytogenetic and Mutagenesis, University Center of Patos de Minas, Patos de Minas, MG, Brazil."}], "LastName": "Orsolin", "ForeName": "Priscila C", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Department of Pharmaceutical Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil."}], "LastName": "Gazolla", "ForeName": "Matheus C", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Department of Pharmaceutical Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil."}], "LastName": "Costa", "ForeName": "Danilo S", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Department of Pharmaceutical Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil."}], "LastName": "da Silva Filho", "ForeName": "Ademar A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Rua Major Jer\u00f4nimo, 566, Sala 601, Patos de Minas, MG, 38700-002, Brazil. tgaraujo@ufu.br."}, {"Identifier": [], "Affiliation": "Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil. tgaraujo@ufu.br."}], "LastName": "Ara\u00fajo", "ForeName": "Thaise G", "Initials": "TG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "ESR1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "ESR2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogen Receptor alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogen Receptor beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Androgen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Bignoniaceae"}, {"QualifierName": [], "DescriptorName": "Biological Assay"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drosophila melanogaster"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["metabolism"], "DescriptorName": "Estrogen Receptor alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "Estrogen Receptor beta"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Androgen"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mokbel K, Mokbel K. Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review. In vivo (Athens, Greece) 2019;33(4):983\u2013997.", "ArticleIdList": ["PMC6689356", "31280187"]}, {"Citation": "Azamjah N, Soltan-Zadeh Y, Zayeri F. Global Trend of Breast Cancer Mortality Rate: A 25-Year Study. APJCP. 2019;20(7):2015\u20132020.", "ArticleIdList": ["PMC6745227", "31350959"]}, {"Citation": "Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315\u2013318.", "ArticleIdList": ["19896917"]}, {"Citation": "WHO: Breast cancer: prevention and control. In.; 2018."}, {"Citation": "Organization WH. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation, vol. 916: World Health Organization; 2003. http://apps.who.int/iris/bitstream/handle/10665/42665/WHO_TRS_916.pdf;jsessionid=C3A75C0BA1D09CE701CD5F60D8A0641B?sequence=1.", "ArticleIdList": ["12768890"]}, {"Citation": "Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Global Oncology. 2020;6:1063\u20131075.", "ArticleIdList": ["PMC7392737", "32673076"]}, {"Citation": "Basch EM, Thaler HT, Shi W, Yakren S, Schrag D. Use of information resources by patients with cancer and their companions. Cancer. 2004;100(11):2476\u20132483.", "ArticleIdList": ["15160355"]}, {"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Lee CI, Goodwin A, Wilcken N. Fulvestrant for hormone-sensitive metastatic breast cancer. Cochrane Database Syst Rev. 2017;1(1):Cd011093.", "ArticleIdList": ["PMC6464820", "28043088"]}, {"Citation": "Gompel A. Hormone and breast cancer. Presse Medicale (Paris, France: 1983) 2019;48(10):1085\u20131091.", "ArticleIdList": ["31662219"]}, {"Citation": "Gerratana L, Basile D, Buono G, De Placido S, Giuliano M, Minichillo S, Coinu A, Martorana F, De Santo I, Del Mastro L, et al. Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype. Cancer Treat Rev. 2018;68:102\u2013110.", "ArticleIdList": ["29940524"]}, {"Citation": "Rangel N, Fortunati N, Osella-Abate S, Annaratone L, Isella C, Catalano MG, Rinella L, Metovic J, Boldorini R, Balmativola D, et al. FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients. BMC Cancer. 2018;18(1):703.", "ArticleIdList": ["PMC6029370", "29970021"]}, {"Citation": "Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Ed\u00e9n P, Peterson C, Malmstr\u00f6m P, Isola J, Borg A, et al. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin Cancer Res. 2007;13(7):1987\u20131994.", "ArticleIdList": ["17404078"]}, {"Citation": "Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Str\u00f6m A, Treuter E, Warner M, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3):905\u2013931.", "ArticleIdList": ["17615392"]}, {"Citation": "Feng J, Li L, Zhang N, Liu J, Zhang L, Gao H, Wang G, Li Y, Zhang Y, Li X, et al. Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. Oncogene. 2017;36(20):2775\u20132790.", "ArticleIdList": ["27893717"]}, {"Citation": "Lamb CA, Vanzulli SI, Lanari C. Hormone receptors in breast cancer: more than estrogen receptors. Medicina. 2019;79(Spec 6/1):540\u2013545.", "ArticleIdList": ["31864223"]}, {"Citation": "Chun KH, Park JH, Fan S. Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer. Adv Exp Med Biol. 2017;1026:59\u2013104.", "ArticleIdList": ["29282680"]}, {"Citation": "Marotti JD, de Abreu FB, Wells WA, Tsongalis GJ. Triple-Negative Breast Cancer: Next-Generation Sequencing for Target Identification. Am J Pathol. 2017;187(10):2133\u20132138.", "ArticleIdList": ["28734944"]}, {"Citation": "Gadi VK, Davidson NE. Practical Approach to Triple-Negative Breast Cancer. J Oncol Pract. 2017;13(5):293\u2013300.", "ArticleIdList": ["28489980"]}, {"Citation": "Kunc M, Biernat W, Senkus-Konefka E. Estrogen receptor-negative progesterone receptor-positive breast cancer - \"Nobody's land\" or just an artifact? Cancer Treat Rev. 2018;67:78\u201387.", "ArticleIdList": ["29772460"]}, {"Citation": "Bak MJ, Furmanski P, Shan NL, Lee HJ, Bao C, Lin Y, Shih WJ, Yang CS, Suh N. Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer. Carcinogenesis. 2018;39(8):1045\u20131055.", "ArticleIdList": ["PMC6067126", "29846560"]}, {"Citation": "Kensler KH, Regan MM, Heng YJ, Baker GM, Pyle ME, Schnitt SJ, Hazra A, Kammler R, Th\u00fcrlimann B, Colleoni M, et al. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98. Breast Cancer Res. 2019;21(1):30.", "ArticleIdList": ["PMC6387478", "30795773"]}, {"Citation": "Shi Q, Li Y, Li S, Jin L, Lai H, Wu Y, Cai Z, Zhu M, Li Q, Li Y, et al. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513.", "ArticleIdList": ["PMC7608661", "33139730"]}, {"Citation": "Wibowo E, Pollock PA, Hollis N, Wassersug RJ. Tamoxifen in men: a review of adverse events. Andrology. 2016;4(5):776\u2013788.", "ArticleIdList": ["27152880"]}, {"Citation": "Cronin-Fenton DP, Damkier P. Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics. Adv Pharmacol (San Diego, Calif) 2018;83:65\u201391.", "ArticleIdList": ["29801584"]}, {"Citation": "Sanchez-Spitman AB, Swen JJ, Dezentje VO, Moes D, Gelderblom H, Guchelaar HJ: Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen. Expert Rev Clin Pharmacol 2019, 12(6):523-536.", "ArticleIdList": ["31008668"]}, {"Citation": "Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, Azoulay L. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2017;28(3):487\u2013496.", "ArticleIdList": ["PMC5834146", "27998966"]}, {"Citation": "Merikhian P, Ghadirian R, Farahmand L, Mansouri S, Majidzadeh AK. MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer. Expert Rev Anticancer Ther. 2017;17(7):607\u2013613.", "ArticleIdList": ["28597750"]}, {"Citation": "Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, et al. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med. 2017;377(19):1836\u20131846.", "ArticleIdList": ["PMC5734609", "29117498"]}, {"Citation": "Turner NC, Slamon DJ, Ro J, Bondarenko I, Im SA, Masuda N, Colleoni M, DeMichele A, Loi S, Verma S, et al. Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer. N Engl J Med. 2018;379(20):1926\u20131936.", "ArticleIdList": ["30345905"]}, {"Citation": "Cristofanilli M, Turner NC, Bondarenko I, Ro J, Im SA, Masuda N, Colleoni M, DeMichele A, Loi S, Verma S, et al. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet Oncol. 2016;17(4):425\u2013439.", "ArticleIdList": ["26947331"]}, {"Citation": "Kim C, Kim B. Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. Nutrients. 2018;10(8):1021.", "ArticleIdList": ["PMC6115829", "30081573"]}, {"Citation": "Jiang P, Han B, Jiang L, Li Y, Yu Y, Xu H, Li Z, Zhou D, Jia X, Li X, et al. Simultaneous separation and quantitation of three phytosterols from the sweet potato, and determination of their anti-breast cancer activity. J Pharm Biomed Anal. 2019;174:718\u2013727.", "ArticleIdList": ["31295647"]}, {"Citation": "Pancholi S, Lykkesfeldt AE, Hilmi C, Banerjee S, Leary A, Drury S, Johnston S, Dowsett M, Martin LA. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocr Relat Cancer. 2008;15(4):985\u20131002.", "ArticleIdList": ["18824559"]}, {"Citation": "De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, et al. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121(1):1\u201311.", "ArticleIdList": ["PMC2995248", "19533338"]}, {"Citation": "Hilborn E, Gacic J, Fornander T, Nordenskj\u00f6ld B, St\u00e5l O, Jansson A. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-\u03b1-negative breast cancer. Br J Cancer. 2016;114(3):248\u2013255.", "ArticleIdList": ["PMC4742586", "26742006"]}, {"Citation": "Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer. 2011;117(16):3703\u20133712.", "ArticleIdList": ["21328328"]}, {"Citation": "Braga DL, Mota STS, Z\u00f3ia MAP, Lima P, Orsolin PC, Vecchi L, Nepomuceno JC, F\u00fcrstenau CR, Maia YCP, Goulart LR et al: Ethanolic Extracts from Azadirachta indica Leaves Modulate Transcriptional Levels of Hormone Receptor Variant in Breast Cancer Cell Lines. International Journal of Molecular Sciences 2018, 19(7).", "ArticleIdList": ["PMC6073126", "29949923"]}, {"Citation": "Alves-Fernandes DK, Oliveira \u00c9A, Fai\u00e3o-Flores F, Alicea-Rebecca G, Weeraratna AT, Smalley KSM, Barros SBM, Maria-Engler SS. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) Pharmacol Res. 2019;141:63\u201372.", "ArticleIdList": ["30550954"]}, {"Citation": "Khamis AAA, Ali EMM, El-Moneim MAA, Abd-Alhaseeb MM, El-Magd MA, Salim EI. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;105:1335\u20131343.", "ArticleIdList": ["30021371"]}, {"Citation": "Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (London, England) 2013;381(9869):805\u2013816.", "ArticleIdList": ["PMC3596060", "23219286"]}, {"Citation": "Ribeiro AFC, Telles TC, Ferraz VP, Souza-Fagundes EM, Cassali GD, Carvalho AT, Melo MM. Effect of Arrabidaea chica extracts on the Ehrlich solid tumor development. Rev Bras Farm. 2012;22(2):364\u2013373."}, {"Citation": "Nepomuceno JC. Using the Drosophila melanogaster to assessment carcinogenic agents through the test for detection of epithelial tumor clones (Warts) Adv Tech Biol Med. 2015;3(3):2\u20138."}, {"Citation": "Vasconcelos MA, Orsolin PC, Oliveira VC, Lima PMAP, Naves MPC, de Morais CR, Nicolau-J\u00fanior N, Bonetti AM, Span\u00f3 MA. Modulating effect of vitamin D3 on the mutagenicity and carcinogenicity of doxorubicin in Drosophila melanogaster and in silico studies. Food Chem Toxicol. 2020;143:111549.", "ArticleIdList": ["PMC7335493", "32640329"]}, {"Citation": "Eeken JC, Klink I, van Veen BL, Pastink A, Ferro W. Induction of epithelial tumors in Drosophila melanogaster heterozygous for the tumor suppressor gene wts. Environ Mol Mutagen. 2002;40(4):277\u2013282.", "ArticleIdList": ["12489118"]}, {"Citation": "Oliveira VC, Constante SAR, Orsolin PC, Nepomuceno JC, de Rezende AAA, Span\u00f3 MA. Modulatory effects of metformin on mutagenicity and epithelial tumor incidence in doxorubicin-treated Drosophila melanogaster. Food Chem Toxicol. 2017;106:283\u2013291.", "ArticleIdList": ["28571774"]}, {"Citation": "Nishiyama Y, Hirota T, Morisaki T, Hara T, Marumoto T. Iida S-i, Makino K, Yamamoto H, Hiraoka T, Kitamura N: A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis. FEBS Lett. 1999;459(2):159\u2013165.", "ArticleIdList": ["10518011"]}, {"Citation": "Orsolin P, Silva-Oliveira R, Nepomuceno J. Modulating effect of simvastatin on the DNA damage induced by doxorubicin in somatic cells of Drosophila melanogaster. Food Chem Toxicol. 2016;90:10\u201317.", "ArticleIdList": ["26829615"]}, {"Citation": "Villegas SN. One hundred years of Drosophila cancer research: no longer in solitude. Dis Model Mech. 2019;12(4):dmm039032.", "ArticleIdList": ["PMC6505481", "30952627"]}, {"Citation": "Silva-Silva JV, Moragas-Tellis CJ, Chagas MSS, Souza PRV, Souza CSF, Hardoim DJ, Taniwaki NN, Moreira DL, Dutra Behrens M, Calabrese KS. Antileishmanial Activity of Flavones-Rich Fraction From Arrabidaea chica Verlot (Bignoniaceae). Front Pharmacol 2021, 12:1843.", "ArticleIdList": ["PMC8329660", "34354593"]}, {"Citation": "Das CK, Parekh A, Parida PK, Bhutia SK, Mandal M. Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Biochimica et biophysica acta Molecular cell research. 2019;1866(6):1004\u20131018.", "ArticleIdList": ["30878502"]}, {"Citation": "Zhou Q, Zeng H, Ye P, Shi Y, Guo J, Long X. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells. Anticancer Drugs. 2018;29(6):539\u2013548.", "ArticleIdList": ["29557813"]}, {"Citation": "Lee MH, Koh D, Na H, Ka NL, Kim S, Kim HJ, Hong S, Shin YK, Seong JK, Lee MO. MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells. Autophagy. 2018;14(5):812\u2013824.", "ArticleIdList": ["PMC6070012", "29130361"]}, {"Citation": "Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM. Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. Sci Rep. 2020;10(1):16992.", "ArticleIdList": ["PMC7552408", "33046784"]}, {"Citation": "Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986;94(1-2):57\u201363.", "ArticleIdList": ["3782817"]}, {"Citation": "Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112\u20131116.", "ArticleIdList": ["17406391"]}, {"Citation": "Dashek WV. Methods in plant biochemistry and molecular biology: CRC Press; 2018. https://www.taylorfrancis.com/books/mono/10.1201/9781351074483/methods-plant-biochemistry-molecular-biology-william-dashek, 10.1201/9781351074483.", "ArticleIdList": ["10.1201/9781351074483/methods-plant-biochemistry-molecular-biology-william-dashek"]}, {"Citation": "Post AE, Smid M, Nagelkerke A, Martens JW, Bussink J, Sweep FC, Span PN. Interferon-stimulated genes are involved in cross-resistance to radiotherapy in tamoxifen-resistant breast cancer. Clin Cancer Res. 2018;24(14):3397\u20133408.", "ArticleIdList": ["29661777"]}, {"Citation": "Lillo MA, Nichols C, Perry C, Runke S, Krutilina R, Seagroves TN, Miranda-Carboni GA, Krum SA. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models. J Appl Toxicol. 2017;37(4):417\u2013425.", "ArticleIdList": ["PMC5338571", "27581495"]}, {"Citation": "Araujo TG, Marangoni K, Rocha RM, Maia YC, Araujo GR, Alc\u00e2ntar TM, Alves PT, Cal\u00e1bria L, Neves AF, Soares FA. Dynamic dialog between cytokeratin 18 and annexin A1 in breast cancer: a transcriptional disequilibrium. Acta Histochem. 2014;116(7):1178\u20131184.", "ArticleIdList": ["25028131"]}, {"Citation": "Costa W, Oliveira A, Nepomuceno J. Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wts. Genet Mol Res. 2011;10(4):3236\u20133245.", "ArticleIdList": ["22194187"]}, {"Citation": "Span\u00f3 MA, Frei H, W\u00fcrgler FE, Graf U. Recombinagenic activity of four compounds in the standard and high bioactivation crosses of Drosophila melanogaster in the wing spot test. Mutagenesis. 2001;16(5):385\u2013394.", "ArticleIdList": ["11507237"]}, {"Citation": "Hultsch S, Kankainen M, Paavolainen L, Kovanen R-M, Ikonen E, Kangaspeska S, Pieti\u00e4inen V, Kallioniemi O. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer. 2018;18(1):850.", "ArticleIdList": ["PMC6109356", "30143015"]}, {"Citation": "Pe\u00f1a E, Roa FJ, Inostroza E, Sotomayor K, Gonz\u00e1lez M, Gutierrez-Castro FA, Maurin M, Sweet K, Labrousse C, Gatica M. Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer. Free Radic Biol Med. 2019;135:283\u2013292.", "ArticleIdList": ["30902760"]}, {"Citation": "Vasconcelos CC, Lopes AJO, Sousa ELF, Camelo DS, Lima FCVM. Rocha CQd, Silva GEB, Garcia JBS, Cart\u00e1genes MdSdS: Effects of extract of arrabidaea chica verlot on an experimental model of osteoarthritis. Int J Mol Sci. 2019;20(19):4717.", "ArticleIdList": ["PMC6801924", "31547612"]}, {"Citation": "Miranda N, Gerola AP, Novello CR, Ueda-Nakamura T, de Oliveira SS, Dias-Filho BP, Hioka N, de Mello JCP, Nakamura CV. Pheophorbide a, a compound isolated from the leaves of Arrabidaea chica, induces photodynamic inactivation of Trypanosoma cruzi. Photodiagnosis Photodyn Ther. 2017;19:256\u2013265.", "ArticleIdList": ["28587855"]}, {"Citation": "Vasconcelos CC, Lopes AJO, Sousa ELF, Camelo DS, Lima F, Rocha CQD, et al. Effects of Extract of Arrabidaea chica Verlot on an Experimental Model of Osteoarthritis. Int J Mol Sci. 2019;20(19).", "ArticleIdList": ["PMC6801924", "31547612"]}, {"Citation": "Nayar U, Cohen O, Kapstad C, Cuoco MS, Waks AG, Wander SA, Painter C, Freeman S, Persky NS, Marini L. Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor\u2013directed therapies. Nat Genet. 2019;51(2):207\u2013216.", "ArticleIdList": ["30531871"]}, {"Citation": "Flaherty RL, Intabli H, Falcinelli M, Bucca G, Hesketh A, Patel BA, Allen MC, Smith CP, Flint MS. Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase. Cancer Lett. 2019;459:59\u201371.", "ArticleIdList": ["31132432"]}, {"Citation": "Fern\u00f6 M, Baldetorp B, Bendahl P-O, Borg \u00c5, Ewers S-B, Olsson H, Ryd\u00e9n S, Sigurdsson H, Killander D. Recurrence-free survival in breast cancer improved by adjuvant tamoxifen-especially for progesterone receptor positive tumors with a high proliferation. Breast Cancer Res Treat. 1995;36(1):23\u201334.", "ArticleIdList": ["7579503"]}, {"Citation": "Wu Y, Zhang Z, Cenciarini ME, Proietti CJ, Amasino M, Hong T, Yang M, Liao Y, Chiang H-C, Kaklamani VG. Tamoxifen resistance in breast cancer is regulated by the EZH2\u2013ER\u03b1\u2013GREB1 transcriptional axis. Cancer Res. 2018;78(3):671\u2013684.", "ArticleIdList": ["PMC5967248", "29212856"]}, {"Citation": "Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y. Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer. EMBO Mol Med. 2019;11(12):e10638.", "ArticleIdList": ["PMC6895605", "31657150"]}, {"Citation": "Neven P, Jongen L, Lintermans A, Van Asten K, Blomme C, Lambrechts D, Poppe A, Wildiers H, Dieudonn\u00e9 A-S, Brouckaert O. Tamoxifen metabolism and efficacy in breast cancer: a prospective multicenter trial. Clin Cancer Res. 2018;24(10):2312\u20132318.", "ArticleIdList": ["29459457"]}, {"Citation": "De Santo I, McCartney A, Migliaccio I, Di Leo A, Malorni L. The emerging role of ESR1 mutations in luminal breast cancer as a prognostic and predictive biomarker of response to endocrine therapy. Cancers. 2019;11(12):1894.", "ArticleIdList": ["PMC6966519", "31795152"]}, {"Citation": "Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283(4):485\u2013491.", "ArticleIdList": ["10659874"]}, {"Citation": "Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res. 1988;48(14):4083\u20134092.", "ArticleIdList": ["3289739"]}, {"Citation": "Kono M, Fujii T, Lim B, Karuturi MS, Tripathy D, Ueno NT. Androgen receptor function and androgen receptor\u2013targeted therapies in breast cancer: a review. JAMA Oncol. 2017;3(9):1266\u20131273.", "ArticleIdList": ["28301631"]}, {"Citation": "Giovannelli P, Di Donato M, Galasso G, Di Zazzo E, Bilancio A, Migliaccio A. The androgen receptor in breast cancer. Front Endocrinol. 2018;9:492.", "ArticleIdList": ["PMC6122126", "30210453"]}, {"Citation": "Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D\u2019Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res. 2014;16(1):1\u201319.", "ArticleIdList": ["PMC3978822", "24451109"]}, {"Citation": "Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23(2):205\u2013212.", "ArticleIdList": ["19898421"]}, {"Citation": "Sommer S, Fuqua SA. Estrogen receptor and breast cancer. In: Seminars in cancer biology: 2001: Elsevier; 2001. p. 339\u201352.", "ArticleIdList": ["11562176"]}, {"Citation": "Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354(3):270\u2013282.", "ArticleIdList": ["16421368"]}, {"Citation": "Maguire P, Margolin S, Skoglund J, Sun X-F, Gustafsson J-\u00c5, B\u00f8rresen-Dale A-L, Lindblom A. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat. 2005;94(2):145\u2013152.", "ArticleIdList": ["16261413"]}, {"Citation": "Yu K-D, Rao N-Y, Chen A-X, Fan L, Yang C, Shao Z-M. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast Cancer Res Treat. 2011;126(1):37\u201345. https://pubmed.ncbi.nlm.nih.gov/20390341/, 10.1007/s10549-010-0891-2.", "ArticleIdList": ["20390341"]}, {"Citation": "Ghali RM, Al-Mutawa MA, Al-Ansari AK, Zaied S, Bhiri H, Mahjoub T, Almawi WY. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study. Gene. 2018;651:194\u2013199.", "ArticleIdList": ["29414691"]}, {"Citation": "Treeck O, Elemenler E, Kriener C, Horn F, Springwald A, Hartmann A, Ortmann O. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility. J Steroid Biochem Mol Biol. 2009;114(3-5):207\u2013211.", "ArticleIdList": ["19429453"]}, {"Citation": "Al-Eitan LN, Rababa\u2019h DM, Alghamdi MA, Khasawneh RH: Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC Cancer 2019, 19(1):1-10.", "ArticleIdList": ["PMC6937757", "31888550"]}, {"Citation": "Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women. PLoS One. 2012;7(7):e40494.", "ArticleIdList": ["PMC3394707", "22792352"]}, {"Citation": "Michel AFRM, Melo MM, Campos PP, Oliveira MS, Oliveira FAS, Cassali GD, Ferraz VP, Cota BB, Andrade SP, Souza-Fagundes EM. Evaluation of anti-inflammatory, antiangiogenic and antiproliferative activities of Arrabidaea chica crude extracts. J Ethnopharmacol. 2015;165:29\u201338.", "ArticleIdList": ["25683298"]}, {"Citation": "dos Santos VC, Longo TB, Garcia ALH, Richter MF, Guecheva TN, Henriques JAP. Ferraz AdBF, Picada JN: Evaluation of the mutagenicity and genotoxicity of Arrabidaea chica Verlot (Bignoneaceae), an Amazon plant with medicinal properties. J Toxicol Environ Health A. 2013;76(6):381\u2013390.", "ArticleIdList": ["23557236"]}, {"Citation": "Gemelli TF. Prado LdS, Santos FS, de Souza AP, Guecheva TN, Henriques JAP, Ferraz AdBF, Corr\u00eaa DS, Dihl RR, Picada JN: Evaluation of safety of Arrabidaea chica verlot (Bignoniaceae), a plant with healing properties. J Toxicol Environ Health A. 2015;78(18):1170\u20131180.", "ArticleIdList": ["26383782"]}, {"Citation": "Benigni R, Bossa C. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology. Mutation Res/Rev Mutation Res. 2008;659(3):248\u2013261.", "ArticleIdList": ["18621573"]}, {"Citation": "Berry C, Brusick D, Cohen SM, Hardisty JF, Grotz VL, Williams GM. Sucralose non-carcinogenicity: a review of the scientific and regulatory rationale. Nutr Cancer. 2016.", "ArticleIdList": ["PMC5152540", "27652616"]}, {"Citation": "Benjanuwattra J, Siri-Angkul N, Chattipakorn SC, Chattipakorn N. Doxorubicin and its proarrhythmic effects: A comprehensive review of the evidence from experimental and clinical studies. Pharmacol Res. 2020;151:104542.", "ArticleIdList": ["31730804"]}, {"Citation": "Broustas CG, Lieberman HB. DNA damage response genes and the development of cancer metastasis. Radiat Res. 2014;181(2):111\u2013130.", "ArticleIdList": ["PMC4064942", "24397478"]}, {"Citation": "Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65(2):157\u2013170.", "ArticleIdList": ["23278683"]}, {"Citation": "Sidorov R, Ugnivenko E, Khovanova E, Belitsky G. Induction of tumor clones in D. melanogaster wts/+ heterozygotes with chemical carcinogens. Mutation Research/Genetic Toxicology and Environmental. Mutagenesis. 2001;498(1-2):181\u2013191.", "ArticleIdList": ["11673083"]}, {"Citation": "Teixeira da Silva T, Braga Martins J, Socorro D, de Brito LM, de Almeida PM, Silva S\u00e1 JL, Alline Martins F. Modulating effect of DL-kavain on the mutagenicity and carcinogenicity induced by doxorubicin in Drosophila melanogaster. J Toxicol Environ Health A. 2021;84(19):769\u2013782.", "ArticleIdList": ["34176449"]}, {"Citation": "Graf U, Abraham SK, Guzm\u00e1n-Rinc\u00f3n J, W\u00fcrgler FE. Antigenotoxicity studies in Drosophila melanogaster. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 1998;402(1-2):203\u2013209.", "ArticleIdList": ["9729134"]}, {"Citation": "Graf U, W\u00fcrgler F, Katz A, Frei H, Juon H, Hall C, Kale P. Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen. 1984;6(2):153\u2013188.", "ArticleIdList": ["6423380"]}, {"Citation": "de Morais CR, Bonetti AM, Mota AA, Campos CF, Souto HN, Naves MPC, Santos VSV, de Campos Junior EO, Pavanin LA, de Rezende AAA. Evaluation of toxicity, mutagenicity and carcinogenicity of samples from domestic and industrial sewage. Chemosphere. 2018;201:342\u2013350.", "ArticleIdList": ["29525663"]}, {"Citation": "Naves MPC, de Morais CR, Span\u00f3 MA, de Rezende AAA. Mutagenicity and recombinogenicity evaluation of bupropion hydrochloride and trazodone hydrochloride in somatic cells of Drosophila melanogaster. Food Chem Toxicol. 2019;131:110557.", "ArticleIdList": ["31176925"]}, {"Citation": "Hernando J, Alvarez L, Ferreiro JA, Sancho I, Comendador MA, Sierra LM. Female germ cell mutagenicity of model chemicals in Drosophila melanogaster: mechanistic information and analysis of repair systems. Mutat Res. 2004;545(1-2):59\u201372.", "ArticleIdList": ["14698417"]}, {"Citation": "Ertu\u011frul H, Yal\u00e7\u0131n B, G\u00fcne\u015f M, Kaya B. Ameliorative effects of melatonin against nano and ionic cobalt induced genotoxicity in two in vivo Drosophila assays. Drug Chem Toxicol. 2020;43(3):279\u2013286.", "ArticleIdList": ["30880493"]}, {"Citation": "Carvajal-Garcia J, Gales ER, Ramsden DA, Sekelsky J: The Drosophila melanogaster Ortholog of RFWD3 Functions Independently of RAD51 During DNA Repair. G3 (Bethesda, Md) 2020, 10(3):999-1004.", "ArticleIdList": ["PMC7056982", "31900333"]}, {"Citation": "Queiroz NCA, Jorge MP, Sousa IMO, Lima CSP, Matias MCM, Dal Rio AC, Pereira EB, Galassi VHK, de Carvalho JE, Galvao TF, et al. Arrabidaea chica for oral mucositis in patients with head and neck cancer: a protocol of a randomised clinical trial. BMJ Open. 2018;8(10):e019505.", "ArticleIdList": ["PMC6196823", "30341109"]}, {"Citation": "Costa Salles TH, Volpe-Zanutto F, de Oliveira Sousa IM, Machado D, Zanatta AC, Vilegas W, Lancellotti M, Foglio MA, d'\u00c1vila MA. Electrospun PCL-based nanofibers Arrabidaea chica Verlot - Pterodon pubescens Benth loaded: synergic effect in fibroblast formation. Biomedical Materials (Bristol, England) 2020;15(6):065001.", "ArticleIdList": ["32955022"]}, {"Citation": "Campos de Siqueira F, Teixeira Costa Leit\u00e3o DDS, Zerlotti Mercadante A, Campos Chist\u00e9 R, Santos Lopes A. Profile of phenolic compounds and carotenoids of Arrabidaea chica leaves and the in vitro singlet oxygen quenching capacity of their hydrophilic extract. Food Res Int (Ottawa, Ont). 2019;126(108597).", "ArticleIdList": ["31732026"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "17"}, {"Year": "2022", "Month": "1", "Day": "7"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "5", "Minute": "42"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35057779", "PMC8773405", "10.1186/s12906-022-03506-3", "10.1186/s12906-022-03506-3"]}}], "PubmedBookArticle": []}